A synthetic peptide for use as a blocking control in assays to test for specificity of CPN1 antibody, Alternative Names: Carboxypeptidase N1 control peptide, Carboxypeptidase N1 antibody Blocking Peptide, Anti-Carboxypeptidase N1 Blocking Peptide, CPN1 Blocking Peptide, CPN Blocking Peptide, FLJ40792 Blocking Peptide, SCPN Blocking Peptide, Carboxypeptidase N Polypeptide 1 Blocking Peptide, Carboxypeptidase N1, Carboxypeptidase N-1, Carboxypeptidase N 1, Carboxypeptidase N-1 Blocking Peptide, Carboxypeptidase N 1 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CPN1
(Carboxypeptidase N Subunit 1 (CPN1))
Hintergrund
Carboxypeptidase N is a plasma metallo-protease that cleaves basic amino acids from the C terminal of peptides and proteins. The enzyme is important in the regulation of peptides like kinins and anaphylatoxins, and has also been known as kininase-1 and anaphylatoxin inactivator. This enzyme is a tetramer comprised of two identical regulatory subunits and two identical catalytic subunits, this gene encodes the catalytic subunit. Mutations in this gene can be associated with angioedema or chronic urticaria resulting from carboxypeptidase N deficiency.